Off-campus University of Richmond users: To download campus access theses, please use the following link to log in to our proxy server with your university username and password.
Date of Award
Restricted Thesis: Campus only access
Bachelor of Science
Dr. John M. Warrick
Machado-Joseph disease (MID), or spino-cerebellar ataxia 3 (SCA-3), is a genetic neurodegenerative disease caused by the mutant ataxin-3 protein, which is characterized by an expansion of a normally occurring polyglutamine domain. It is one member of a family of diseases in which a normally occurring glutamine repeat within the protein has been expanded two to three times its normal length. This late onset disease causes severe neurological dysfunction, including loss of motor control, inability to swallow and frequent urination (1). The molecular hallmark of MID is the formation of nuclear inclusion bodies, which are aggregates of mutant ataxin-3 that trap cellular components linked to the proteasome as well as chaperones and transcription factors (2).
Expression of the truncated mutant ataxin-3 protein in the eyes and brain of the fruit fly Drosophila melanogaster has been found to cause severe neurodegeneration in those organs as well as cause loss of visual function and premature death (3). With conserved degenerative gene products being expressed, homologous modifiers of the disease can be expressed too. Previous research using a truncated form of the ataxin-3 protein has shown that modulation of various molecular chaperones and endogenous chromatin modifiers can have various effects on the pathology of MID.
Sebesto, Jason, "Modulation of hHsp70 and dCBP in a full-length Drosophila model of MJD" (2005). Honors Theses. 742.